Journal of Public Health

, Volume 24, Issue 6, pp 489–495 | Cite as

Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents

  • Caroline Parchetka
  • Nicole Strache
  • Bianca Raffaelli
  • Isabel Gemmeke
  • Katharina Weiß
  • Eric Artiges
  • Tobias Banaschewski
  • Arun Bokde
  • Uli Bromberg
  • Christian Buechel
  • Patricia Conrod
  • Sylvane Desrivières
  • Herta Flor
  • Vincent Frouin
  • Hugh Garavan
  • Penny Gowland
  • Andreas Heinz
  • Bernd Ittermann
  • Herve Lemaitre
  • Jean-Luc Martinot
  • Eva Mennigen
  • Frauke Nees
  • Marie-Laure Paillère Martinot
  • Dimitri Papadopoulos
  • Tomáš Paus
  • Luise Poustka
  • Sarah Jurk
  • Michael N. Smolka
  • Nora C. Vetter
  • Henrik Walter
  • Robert Whelan
  • Gunter Schumann
  • Juergen Gallinat
  • and the IMAGEN consortium
Original Article

Abstract

Purpose

The onset of substance use mostly occurs during adolescence. The aim of the present study is to investigate the relevance of personality on the basis of the NEO-Five-Factor Inventory (NEO-FFI) to future experiences with tobacco, alcohol and cannabis.

Methods

The test data were derived from the baseline assessment and first follow-up of the IMAGEN study, a European multicenter and multidisciplinary research project on adolescent mental health. In the present study 1004 participants were tested. The characterization of personality was conducted with the NEO-FFI at the age of 14 (T1). The data on substance use were collected with the European School Survey Project on Alcohol and Other Drugs (ESPAD) questionnaire at the age of 16 (T2). For the statistical analysis, t-tests and univariate analyses of variance were performed.

Results

The scores of Conscientiousness at T1 were significantly lower for adolescents with tobacco, alcohol and cannabis experiences at T2. We found lower scores of Agreeableness at T1 in participants with tobacco and cannabis use at T2. Extraversion at T1 was significantly higher for adolescents with smoking experiences at T2. No significant associations between Neuroticism or Openness and future substance use were observed.

Conclusion

Low scores of Conscientiousness and Agreeableness seem to have the greatest value for a prediction of later experiences with substance use. As the present study is the first one to examine the predictive value of the NEO-FFI for future substance use in an adolescent sample, further studies are necessary to enable a better applicability in a clinical context.

Keywords

Adolescence Personality Five-factor model of personality NEO-FFI Substance use 

References

  1. Battistella G, Fornari E, Annoni JM, Chtioui H, Dao K, Fabritius M, Favrat B, Mall JF, Maeder P, Giroud C (2014) Long-term effects of cannabis on brain structure. Neuropsychopharmacology 39(9):2041–2048. doi:10.1038/npp.2014.67 PubMedPubMedCentralGoogle Scholar
  2. Centers for Disease Control & Prevention (2008) Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR Morb Mortal Wkly Rep 57(45):1226–1228Google Scholar
  3. Clark A, Tran C, Weiss A, Caselli G, Nikcevic AV, Spada MM (2012) Personality and alcohol metacognitions as predictors of weekly levels of alcohol use in binge drinking university students. Addict Behav 37(4):537–540. doi:10.1016/j.addbeh.2011.11.035 CrossRefPubMedGoogle Scholar
  4. De Sousa KR, Tiwari AK, Giuffra DE, Mackenzie B, Zai CC, Kennedy JL (2013) Age at onset of schizophrenia: cannabis, COMT gene, and their interactions. Schizophr Res 151(1–3):289–290. doi:10.1016/j.schres.2013.10.037 CrossRefPubMedGoogle Scholar
  5. DeWit DJ, Adlaf EM, Offord DR, Ogborne AC (2000) Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry 157(5):745–750CrossRefPubMedGoogle Scholar
  6. Dierker L, Selya A, Piasecki T, Rose J, Mermelstein R (2013) Alcohol problems as a signal for sensitivity to nicotine dependence and future smoking. Drug Alcohol Depend 132(3):688–693. doi:10.1016/j.drugalcdep.2013.03.018 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Fridberg DJ, Vollmer JM, O’Donnell BF, Skosnik PD (2011) Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res 186(1):46–52. doi:10.1016/j.psychres.2010.07.035 CrossRefPubMedPubMedCentralGoogle Scholar
  8. Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staedtgen M (2006) Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 24(6):1744–1750. doi:10.1111/j.1460-9568.2006.05050.x CrossRefPubMedGoogle Scholar
  9. Grant JD, Scherrer JF, Lynskey MT, Lyons MJ, Eisen SA, Tsuang MT, True WR, Bucholz KK (2006) Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: evidence from a twin design. Psychol Med 36(1):109–118. doi:10.1017/S0033291705006045 CrossRefPubMedGoogle Scholar
  10. Hibell B, Andersson B, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, Morgan M (2000) The 1999 ESPAD report. Alcohol and other drug use among students in 30 European Countries. The Swedish Council for Information on Alcohol and Other Drugs, StockholmGoogle Scholar
  11. Hibell B, Andersson B, Bjarnason T, Ahlström S, Balakireva O, Kokkevi A, Morgan M (2004) The ESPAD report 2003. Alcohol and other drug use among students in 35 European countries. The Swedish Council for Information on Alcohol and Other Drugs, StockholmGoogle Scholar
  12. Hinckers AS, Laucht M, Schmidt MH, Mann KF, Schumann G, Schuckit MA, Heinz A (2006) Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents. Biol Psychiatry 60(3):282–287. doi:10.1016/j.biopsych.2005.12.009 CrossRefPubMedGoogle Scholar
  13. Hyman SM, Sinha R (2009) Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J Subst Abus Treat 36(4):400–413. doi:10.1016/j.jsat.2008.08.005 CrossRefGoogle Scholar
  14. Kandel D, Yamaguchi K (1993) From beer to crack: developmental patterns of drug involvement. Am J Public Health 83(6):851–855CrossRefPubMedPubMedCentralGoogle Scholar
  15. Kuhn S, Romanowski A, Schilling C, Mobascher A, Warbrick T, Winterer G, Gallinat J (2012) Brain grey matter deficits in smokers: focus on the cerebellum. Brain Struct Funct 217(2):517–522. doi:10.1007/s00429-011-0346-5 CrossRefPubMedGoogle Scholar
  16. Malouff JM, Thorsteinsson EB, Rooke SE, Schutte NS (2007) Alcohol involvement and the Five-Factor model of personality: a meta-analysis. J Drug Educ 37(3):277–294CrossRefPubMedGoogle Scholar
  17. McCann SJ (2010) Subjective well-being, personality, demographic variables, and American state differences in smoking prevalence. Nicotine Tob Res 12(9):895–904. doi:10.1093/ntr/ntq113 CrossRefPubMedGoogle Scholar
  18. McCrae RR, John OP (1992) An introduction to the five-factor model and its applications. J Pers 60(2):175–215CrossRefPubMedGoogle Scholar
  19. Pluess M, Bartley M (2015) Childhood conscientiousness predicts the social gradient of smoking in adulthood: a life course analysis. J Epidemiol Community Health 69(4):330–338. doi:10.1136/jech-2014-204263 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Prescott CA, Kendler KS (2001) Early age at first alcoholic drink. Am J Psychiatry 158(9):1530CrossRefPubMedGoogle Scholar
  21. Salujha SK, Chaudhury S, Menon PK, Srivastava K, Gupta A (2014) Allelic variants of ADH, ALDH and the five factor model of personality in alcohol dependence syndrome. Ind Psychiatry J 23(1):44–51. doi:10.4103/0972-6748.144956 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Mallik C, Mann K, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Reed L, Smolka M, Spanagel R, Speiser C, Stephens DN, Strohle A, Struve M, and The IMAGEN consortium (2010) The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 15(12):1128–1139. doi:10.1038/mp.2010.4 CrossRefPubMedGoogle Scholar
  23. Vollrath ME, Torgersen S (2008) Personality types and risky health behaviors in Norwegian students. Scand J Psychol 49(3):287–292. doi:10.1111/j.1467-9450.2008.00631.x CrossRefPubMedGoogle Scholar
  24. Waga C, Iwahashi K (2007) CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths. Drug Chem Toxicol 30(4):343–349. doi:10.1080/01480540701522338 CrossRefPubMedGoogle Scholar
  25. Whelan R, Watts R, Orr CA, Althoff RR, Artiges E, Banaschewski T, Barker GJ, Bokde AL, Buchel C, Carvalho FM, Conrod PJ, Flor H, Fauth-Buhler M, Frouin V, Gallinat J, Gan G, Gowland P, Heinz A, Ittermann B, Lawrence C, Mann K, Martinot JL, Nees F, Ortiz N, Paillere-Martinot ML, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Strohle A, Schumann G, Garavan H, The IMAGEN consortium (2014) Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 512(7513):185–189. doi:10.1038/nature13402 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Woicik PA, Stewart SH, Pihl RO, Conrod PJ (2009) The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles. Addict Behav 34(12):1042–1055. doi:10.1016/j.addbeh.2009.07.001 CrossRefPubMedGoogle Scholar
  27. Zvolensky MJ, Taha F, Bono A, Goodwin RD (2015) Big five personality factors and cigarette smoking: a 10-year study among US adults. J Psychiatr Res. doi:10.1016/j.jpsychires.2015.02.008 PubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Caroline Parchetka
    • 1
  • Nicole Strache
    • 1
  • Bianca Raffaelli
    • 1
  • Isabel Gemmeke
    • 1
  • Katharina Weiß
    • 1
  • Eric Artiges
    • 2
    • 3
    • 4
    • 5
  • Tobias Banaschewski
    • 6
  • Arun Bokde
    • 7
  • Uli Bromberg
    • 8
  • Christian Buechel
    • 8
  • Patricia Conrod
    • 9
    • 10
  • Sylvane Desrivières
    • 9
  • Herta Flor
    • 11
  • Vincent Frouin
    • 12
  • Hugh Garavan
    • 13
  • Penny Gowland
    • 14
  • Andreas Heinz
    • 1
  • Bernd Ittermann
    • 15
  • Herve Lemaitre
    • 2
    • 4
    • 16
  • Jean-Luc Martinot
    • 2
    • 3
    • 4
  • Eva Mennigen
    • 17
  • Frauke Nees
    • 11
  • Marie-Laure Paillère Martinot
    • 2
    • 3
    • 4
    • 18
  • Dimitri Papadopoulos
    • 12
  • Tomáš Paus
    • 19
  • Luise Poustka
    • 6
  • Sarah Jurk
    • 17
  • Michael N. Smolka
    • 17
  • Nora C. Vetter
    • 17
  • Henrik Walter
    • 1
  • Robert Whelan
    • 7
  • Gunter Schumann
    • 9
    • 20
  • Juergen Gallinat
    • 21
  • and the IMAGEN consortium
  1. 1.Department of Psychiatry and Psychotherapy, Campus Charité Mitte, CharitéUniversitätsmedizin BerlinBerlinGermany
  2. 2.INSERM, UMR 1000, Research unit Imaging and PsychiatryCEA, DSV, I²BM-Service Hospitalier Frédéric JoliotOrsayFrance
  3. 3.University Paris-Sud 11OrsayFrance
  4. 4.University Paris Descartes, Sorbonne Paris CitéParisFrance
  5. 5.Psychiatry Department 91G16Orsay HospitalOrsayFrance
  6. 6.Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg UniversityMannheimGermany
  7. 7.Discipline of Psychiatry, School of Medicine and Trinity College Institute of NeurosciencesTrinity College DublinDublinIreland
  8. 8.University Medical Centre Hamburg-EppendorfHamburgGermany
  9. 9.Institute of Psychiatry, Psychology & NeuroscienceKing’s College LondonLondonUK
  10. 10.Department of Psychiatry, CHU Ste Justine HospitalUniversite de MontrealMontrealCanada
  11. 11.Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg UniversityMannheimGermany
  12. 12.Neurospin, Commissariat à l’Energie Atomique, CEA-Saclay CenterParisFrance
  13. 13.Departments of Psychiatry and PsychologyUniversity of VermontBurlingtonUSA
  14. 14.School of PsychologyUniversity of NottinghamNottinghamUK
  15. 15.Physikalisch-Technische Bundesanstalt (PTB)BerlinGermany
  16. 16.Faculté de médecineUniversité Paris-SudLe Kremlin-BicêtreFrance
  17. 17.Department of Psychiatry and Neuroimaging CenterTechnische Universität DresdenDresdenGermany
  18. 18.AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de SolennCochin HospitalParisFrance
  19. 19.Rotman Research Institute, Baycrest and Departments of Psychology and PsychiatryUniversity of TorontoTorontoCanada
  20. 20.Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of PsychiatryKing’s College LondonLondonUK
  21. 21.Department of Psychiatry and PsychotherapyUniversity Medical Center Hamburg-Eppendorf (UKE)20246 HamburgGermany

Personalised recommendations